New Jersey 2022-2023 Regular Session

New Jersey Senate Bill SJR104

Introduced
10/13/22  

Caption

Designates last day of February of each year as "Rare Disease Awareness Day" in New Jersey.

Impact

The introduction of SJR104 signifies an important step in the state's recognition of rare diseases as a significant public health issue. By declaring a specific day as Rare Disease Awareness Day, the state government is committing to promoting initiatives that can lead to improved awareness and support for those affected. This resolution also implicitly encourages lawmakers and healthcare professionals to discuss and address policies that can facilitate better access to treatments and resources for patients with rare diseases.

Summary

Senate Joint Resolution 104 (SJR104) proposes to designate the last day of February each year as 'Rare Disease Awareness Day' in New Jersey. The intention behind this resolution is to raise public awareness concerning rare diseases and to foster support for patients and families affected by these conditions. Given the substantial number of individuals in the U.S. affected by rare diseases, nearly 30 million according to the National Institutes of Health, the resolution aims to shine a light on the challenges that these patients face, including the isolation often caused by their conditions and the difficulty in obtaining accurate diagnoses and effective treatments.

Contention

While the bill has a generally positive reception due to its aims of raising awareness, there may be underlying concerns regarding the effectiveness of such observances. Some stakeholders might argue that merely designating a day does not translate into real-world changes for patients suffering from rare diseases. Critics may emphasize the need for more concrete legislative actions that address the systemic issues faced by those with rare diseases, such as lack of funding for research and inadequate insurance coverage for treatments. Thus, the resolution could prompt discussions on whether more needs to be done beyond awareness campaigns to support patients adequately.

Companion Bills

NJ AJR227

Same As Designates last day of February of each year as "Rare Disease Awareness Day" in New Jersey.

Previously Filed As

NJ SJR88

Designates last day of February of each year as "Rare Disease Awareness Day" in New Jersey.

NJ AJR114

Designates last day of February of each year as "Rare Disease Awareness Day" in New Jersey.

NJ AJR19

Designates May 7 of each year as "Cystinosis Awareness Day" in New Jersey.

NJ AJR141

Designates March 1 of each year as "Endometriosis Awareness Day" in New Jersey.

NJ AJR185

Designates May of each year as "Asthma and Allergy Awareness Month" in New Jersey.

NJ AJR139

Designates month of September each year as "Deaf Awareness Month" in New Jersey; designates last full week of September each year as "Deaf Awareness Week" in New Jersey.

NJ AJR175

Designates February 22 of each year as "Peter Still Day" in New Jersey.

NJ SJR30

Designates October of each year as "Eczema Awareness Month" in New Jersey.

NJ SJR144

Designates February 22 of each year as "Peter Still Day" in New Jersey.

NJ SJR27

Permanently designates last week in February as "Eating Disorders Awareness Week" in New Jersey.

Similar Bills

WI AB925

Revising various provisions of the statutes for the purpose of making corrections and reconciling conflicts (Correction Bill).

AZ HB2944

Inpatient treatment days; computation; exclusion

CA AB1879

Substance use: treatment or residential data reporting.

WI SB904

Revising various provisions of the statutes for the purpose of making corrections and reconciling conflicts (Correction Bill).

CA AB2538

Medi-Cal: hospice providers: forms.

AZ SB1244

court-ordered treatment; continuation

IA HF518

A bill for an act establishing a veterans recovery pilot program and fund for the reimbursement of expenses related to providing hyperbaric oxygen treatment to eligible veterans and making appropriations.(Formerly HF 326.)

IA HF326

A bill for an act establishing a veterans recovery pilot program and fund for the reimbursement of expenses related to providing hyperbaric oxygen treatment to eligible veterans and making appropriations.(See HF 518.)